Glycopyrrolate Injection, Solution
Product Images NDC 71872-7174

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Glycopyrrolate (NDC 71872-7174). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Medical Purchasing Solutions, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

71872-7174-1 Pdp (7174)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL solution in a 1 mL single-dose vial. Label indicates intramuscular or intravenous administration, contains benzyl alcohol, and advises against use in newborns. Manufactured for Piramal Critical Care, repackaged and distributed by Medical Purchasing Solutions, Scottsdale, AZ.*

FDA Label Image

Glyco 1 mL Label (Glyco 1 mL Label)

Label for Glycopyrrolate Injection, USP 0.2 mg/mL solution for intramuscular or intravenous use. The single dose vial contains 1 mL and includes benzyl alcohol as a preservative. Manufactured for Piramal Critical Care, Bethlehelm, PA, USA, product of India. Label includes NDC 66794-202-02 and barcode.*

FDA Label Image

Glycopyrrolate Injection Usp, 0.2 mg/ mL (logo)

FDA Label Image

Glycopyrrolate Structure (Glycopyrrolate Str)

Chemical structure of Glycopyrrolate, showing its molecular framework with molecular formula C19H28BrNO3 and molecular weight 398.33.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.